View in EDS

Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

Saved in:

Bibliographic Details
Title:	Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
Authors:	Masi, Gianluca¹ gl.masi@tin.it, Loupakis, Fotios¹, Salvatore, Lisa¹, Fornaro, Lorenzo¹, Cremolini, Chiara¹, Cupini, Samanta², Ciarlo, Andrea³, Del Monte, Francesca³, Cortesi, Enrico⁴, Amoroso, Domenico⁵, Granetto, Cristina⁶, Fontanini, Gabriella⁷, Sensi, Elisa⁷, Lupi, Cristiana⁷, Andreuccetti, Michele¹, Falcone, Alfredo¹
Source:	Lancet Oncology. Sep2010, Vol. 11 Issue 9, p845-852. 8p.
Database:	Academic Search Ultimate

Description
ISSN:	14702045
DOI:	10.1016/S1470-2045(10)70175-3